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doi:10.1016/j.jmu.2011.05.002A 21-year-old male patient presented with the symptoms of weakness in both legs, urine and
stool incontinence for several months. Neurological examination revealed flaccid bilateral leg.
Sonography showed heterogeneously echogenic multilobulated soft-tissue mass with several
cystic spaces within it. Magnetic resonance imaging showed iso-signal intensity soft-tissue
mass in T1 weighted imaging with many high-signal intensity cystic areas. After intravenous
administration of gadolinium contrast agent, the tumor showed moderate contrast enhance-
ment. The most common sarcomatous lesions with cystic degeneration include chondroid
tumor (such as chondrosarcoma), liposarcoma, synovial sarcoma, and malignant peripheral
nerve sheath tumors. Tumor biopsy showed malignant peripheral nerve sheath tumor. The
patient received arterial embolization, radiotherapy, and regular chemotherapy after the
diagnostic workup.
ª 2011, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Introduction
Malignant peripheral nerve sheath tumors (MPNSTs) most
commonly occur in the deep soft tissues, usually close to
a nerve trunk [1]. The most common sites are the sciatic
nerve, brachial plexus, and sacral plexus. MPNSTs and neu-
rosarcomas are not uncommon in adolescents and adults-Hong Chou, Taipei Veterans
Shipai Road, Beitou District,
@vghtpe.gov.tw (Y.-H. Chou).
C and the Chinese Taipei Societywith neurofibromatosis Type 1 (NF1), with an approximate
lifetime risk of 10%. These malignancies frequently arise
from large plexiform neurofibromas or extensive peripheral
nerve lesions [2,3].
We herein presented a case of a giant MPNST at sacral
region with presentation of bilateral leg weakness, accom-
panied by urine and stool incontinence for several months.
Case Report
A 20-year-old male patient had a history of NF for 15 years.
A mass over his left face was noted years ago. He hadof Ultrasound in Medicine.Open access under CC BY-NC-ND license.
Fig. 1. Pelvic X-ray image shows increased soft-tissue
density in the pelvic cavity. Loss of normal cortical outline of
the upper sacral bone (arrows) is noted.
Fig. 2. Pelvic sonography: (A, B) transverse scans, (C, D) sagittal
region, composed of solid components, some irregular cystic spac
(arrows), compatible with a tumor such as sarcomatous lesion or ch
tumor demonstrates color flow signals in the peripheral zone (dot
Malignant Peripheral Nerve Sheath Tumor at Sacral Region 53received surgical intervention for his face mass at another
medical center 5 years ago and operation scar was found
over his left face. A mass over lower back was detected in
recent years. The patient and his family did not pay
attention to it seriously. However, the mass enlarged
progressively. Urine and stool incontinence occurred later.
Bilateral legs weakness happened 3 months ago and paral-
ysis developed 2 weeks ago. He was transferred to our
hospital for further evaluation and management.
Plain film of pelvis revealed increased soft-tissue density
in the pelvic cavity. Loss of normal cortical outline of the
upper sacrum with bone destruction is considered (Fig. 1).
Sonography disclosed a heteroechoic mass, composed of
echogenic solid component, some irregular cystic spaces,
associated with coarse calcifications in the pelvic cavity.
The estimated greatest dimension was 15 cm. The sono-
graphic pattern is compatible with neoplasm such as
sarcomatous tumor or chordoma (Fig. 2).
Magnetic resonance imaging (MRI) of the lumbar spine
and sacrum before and after intravenous gadolinium
injection was performed. A huge tumor mass about 15 cm in
size was found in the upper pelvic cavity with severe
destruction of the sacrum and intraspinal extension to
lumbosacral junction causing obliteration of the dural sac.
The differential diagnoses included unusual neurogenic
tumor (neurofibroma, neurofibrosarcoma), unusal chor-
doma, and giant cell tumor (Fig. 3). The thoracic spine and
thoracic spinal cord are well preserved in MRI.scans. A heterogeneously echogenic mass is noted in the pelvic
es (curved arrows), and associated with coarse calcifications
ordoma. Color Doppler sonography with sagittal scan (D) of the
arrows), compatible with a hypervascular tumor.
Fig. 3. Magnetic resonance imaging (MRI) of the pelvis: a huge lobulated tumor mass is demonstrated occupying the upper pelvic
cavity with heterogeneous enhancement, complete destruction of the sacrum, focal destruction of bilateral pelvic bones. (A) Axial
SE T1WI at iliac wing and femoral head level, (B) Axial FSE T2WI, both show lobulated tumor with multiple cystic areas.
(C) Contrast-enhanced MRI, axial SE fat-saturated T1WI and (D) Contrast-enhanced MRI, sagittal SE fat-saturated T1WI show the
extension of the tumor (arrows).
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was performed and revealed at least 20 variable size soft-
tissue nodules in both lung fields, compatible with
multiple lung metastases. The whole body bone scan
showed destruction at sacrum and bilateral sacroiliac
junctions. There were no evidences of bony abnormality in
other skeleton. Then tumor biopsy was arranged and
pathology report proved to be MPNST. Trans-arterial
embolization therapy and radiotherapy were performed
for further treatment. Postchemotherapy, the patient felt
general weakness after chemotherapy. Because no major
complication occurred after chemotherapy, he was dis-
charged and received regular chemotherapy at our onco-
logic clinic.Discussion
MPNSTs arise in patients with or without associated NF.
Tumors that arise in the absence of NF are somewhat more
common in large series of MPNSTs [1]. Men and women are
equally affected by this tumor. Most tumors occur in
patients between 20 years and 50 years of age. MPNSTs may
arise from plexiform neurofibromas, de novo or secondary
to radiation therapy [2e4]. These tumors tend to present
with masses larger than 6 cm with irregular borders and
a history of rapid growth. MPNST often produces neurologic
deficits in the distribution of the involved nerves because of
impingement or mass effect [5].
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indistinguishable; however, certain modalities may provide
insight for differentiation [5]. Recent advances in ultra-
sound (US) technology have enabled the echotexture of
soft-tissue tumors to be presented in greater detail. The
following major parameters should be determined: echo-
genicity, contour, margin, composition, size, related
surrounding tissue in grayscale ultrasonography, the grading
of color Doppler US, and resistive index in spectral Doppler.
Many more specific patterns can be observed, including
phleboliths, hyperechoic fat lobules, central necrosis, and
internal calcification [6].
Both benign peripheral nerve sheath tumors (schwan-
nomas and neurofibromas) and MPNSTs have variable
sonographic features. The target appearance on sonog-
raphy (hyperechoic center with a hypoechoic periphery)
described by Lin et al [7] was presented in most benign
peripheral nerve sheath tumors. The target appearance has
been attributed to a central fibrocollagenous region and
a peripheral myxomatous region [8]. No MPNSTs showed
a target appearance, which is similar to findings described
with MRI [10].
MPNST usually presents heterogeneous hypoechogenicity,
infiltrated margins, scalloped or ovoid contour, solid
content, large size, and mild to moderate vascularity on
color Doppler US [6]. The sonographic appearance of
MPNSTs depends on their histologic characteristics. They
are composed of Schwann cells and fibroblasts and are
accompanied by variable amounts of myxoid change [9].
Myxoid changes demonstrate significant differences in
biological behavior, ranging from completely harmless to
malignant transformation [2]. Sonography may show
heterogeneous hypoechoic lesion with infiltrated margins.
They typically have multiple internal hypoechoic cystic
areas, which may be related to the high water content of
myxoid tissue, and cystic changes secondary to hemorrhage
and/or necrosis [10]. Peripheral hyperechoic areas with
central nodules may be seen because of the fat content of
myelin from Schwann cells, the less cellular myxoid tissue
located in the periphery or the more vascular fibrous tissue
was seen centrally.
In addition, our cases displayed some internal punctate
echogenic calcification, which has been described as rare
but virtually pathognomonic of nerve tumors [11]. A MPNSTs
that have undergone degenerative change may usually have
calcification [12]. This calcification is pathognomonic and
can be differentiated from myxoid type liposarcoma (the
most common liposarcoma) [7]. In well-differentiated lip-
osarcoma, US usually reveals hyperechogenicity. However,
in myxoid change of liposarcoma, some mature fat cells or
lipoblasts could still exist within the tumor, resulting in
focal hyperechoic areas. US usually appears heterogeneous
and hypoechoic with hyperechoic areas, which retains lip-
oblast nets.
Most MPNSTs were hyperemic on color and power
Doppler sonography, as in other malignant tumors. But
hyperemia was rarely present in benign peripheral nerve
sheath tumors [13]. The characteristic dumbbell lesion,
a partly intradural and partly extradural tumor, represents
a neurofibroma that expands the intervertebral foramina
and may be detected with ultrasonography [2,14].Surrounding bony destruction, amorphous bony fragments,
and widening of intervertebral foramina is observed in most
patients [6]. The ultrasonographic appearance of MPNSTs
with bony destruction differs to that of osteogenic sarcoma
because they present without the sunburst periosteal
reaction.
MRI findings depend largely on the histopathological
characteristics of the tumor. MPNSTs show low to interme-
diate signal intensity on T1 weighted images and hetero-
geneous signal intensity on T2 weighted images. The
hyperintense regions on T2 weighted images correspond to
areas of cystic degeneration or myxoid matrix, whereas the
hypointense regions represent collagen and fibrous tissue
[15]. Hypointense areas on T2 weighted images may
enhance following gadolinium administration [10].
A malignant contrast enhancement pattern is an expected
finding in neurofibromas with sarcomatous changes.
Surgical resection is the first choice of therapy, ideally
with total removal of the tumor. Owing to a high risk of
recurrence with incomplete resection, postoperative irra-
diation and chemotherapy are necessary; however, they
are often used as adjuvant therapies even if the tumor is
completely resected. Even with aggressive therapy, local
recurrence of tumor is seen in 50% of patients [2]. Hema-
togenous metastatic spread occurs most commonly to the
lungs. The reported 5-year survival rate for patients with
MPNST without NF1 is as high as 50%. It drops to as low as
10% for MPNST patients with NF1 [16].References
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